Oramed Pharmaceuticals
ORMP
#9182
Rank
ยฃ0.13 B
Marketcap
ยฃ3.29
Share price
-0.68%
Change (1 day)
80.15%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): ยฃ46.64 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of ยฃ47.06 Million, an increase over its 2024 earnings that were of -ยฃ11.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ46.64 M-0.89%
2025 ยฃ47.06 M-513.21%
2024 -ยฃ11.4 Million-311.47%
2023 ยฃ5.38 M-119.45%
2022 -ยฃ27.7 Million39.17%
2021 -ยฃ19.9 Million73.93%
2020 -ยฃ11.44 Million18.53%
2019 -ยฃ9.66 Million-16.62%
2018 -ยฃ11.58 Million38.32%
2017 -ยฃ8.37 Million12.51%
2016 -ยฃ7.44 Million25.01%
2015 -ยฃ5.95 Million18.18%
2014 -ยฃ5.04 Million39.72%
2013 -ยฃ3.61 Million46.4%
2012 -ยฃ2.47 Million128.32%
2011 -ยฃ1.08 Million-51.47%
2010 -ยฃ2.23 Million35.21%
2009 -ยฃ1.65 Million
2007 -ยฃ2.59 Million607.04%
2006 -ยฃ0.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
ยฃ17.55 B 36,862.42%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
ยฃ5.41 B 11,297.56%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-ยฃ0.39 Billion-904.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-ยฃ46.21 Million-197.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
ยฃ26.37 M-44.47%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel